PCM
ASPX

Prelude Capital Management’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Prelude Capital Management’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-17,691
Closed -$1.77M – 2360
2015
Q1 		$1.77M Buy
+17,691
New +$1.18M 0.25% 96

Prelude Capital Management's ASPX Position: Q2 2015 in Review

Prelude Capital Management sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 17,691 shares — an estimated $1.77M sold.

Prelude Capital Management first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $1.77M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Prelude Capital Management reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Prelude Capital Management sold 17,691 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1.77M.
  • Prelude Capital Management first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Prelude Capital Management's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.77M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Prelude Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.